UniSuper Management Pty Ltd

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1989400 MELBOURNE, VICTORIA, C3

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,902,975

+$5,124,892 QoQ

Shares Held

27,989

+42.4% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#310

of 1,735 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UniSuper Management Pty Ltd holds $27,620,777 across 8 Biotechnology names. VRTX ranks #1 (50.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	27,989	$13,902,975
2	REGN	Regeneron Pharmaceuticals, Inc.	11,299	$7,045,378
3	INCY	Incyte Corp	15,515	$1,758,780
4	MRNA	Moderna, Inc.	23,601	$1,652,778
5	ALNY	Alnylam Pharmaceuticals, Inc.	3,687	$1,109,897
6	RVMD	Revolution Medicines, Inc.	4,589	$859,427
7	TECH	BIO-TECHNE Corp	10,616	$750,020
8	INSM	INSMED Inc	5,079	$541,522

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,902,975	27,989	+42.4%	Shares	Sole	2026-08-14
2026-03-31	$8,778,083	19,658	-1.7%	Shares	Sole	2026-05-11
2025-12-31	$9,063,573	19,992	-2.5%	Shares	Sole	2026-02-12
2025-09-30	$8,026,661	20,495	+23.1%	Shares	Sole	2025-10-31
2025-06-30	$7,411,689	16,648	-1.1%	Shares	Sole	2025-07-22
2025-03-31	$8,162,914	16,837	+3.5%	Shares	Sole	2025-05-15
2024-12-31	$6,553,539	16,274	+32.8%	Shares	Sole	2025-02-12
2024-09-30	$5,700,485	12,257	+1.7%	Shares	Sole	2024-11-14
2024-06-30	$5,651,357	12,057	+106.7%	Shares	Sole	2024-08-05
2024-03-31	$2,437,834	5,832	+179.2%	Shares	Sole	2024-05-13
2023-12-31	$849,993	2,089	-46.8%	Shares	Sole	2024-02-13
2023-09-30	$1,365,922	3,928	-10.1%	Shares	Sole	2023-11-13
2023-06-30	$1,536,790	4,367	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.